Literature DB >> 20592686

West Nile virus activity - United States, 2009.

.   

Abstract

West Nile virus (WNV) was first detected in the Western Hemisphere in 1999 in New York City and has since caused seasonal epidemics of febrile illness and neurologic disease across the United States, where it is now the leading cause of arboviral encephalitis. This report updates a previous report and summarizes WNV activity in the United States reported to CDC in 2009. A total of 38 states and the District of Columbia (DC) reported 720 cases of WNV disease. Of these, 33 states and DC reported 386 cases of WNV neuroinvasive disease, for an incidence of 0.13 per 100,000 population. The five states with the highest incidence of WNV neuroinvasive disease were Mississippi (1.05 per 100,000), South Dakota (0.74), Wyoming (0.73), Colorado (0.72), and Nebraska (0.61). Neuroinvasive disease incidence increased with increasing age, with the highest incidence among persons aged >or=70 years. A total of 33 WNV deaths were reported, 32 from neuroinvasive disease. Calculating from the number of neuroinvasive disease cases and projections from 1999 serosurvey data, CDC estimated that 54,000 persons were infected with WNV in 2009, of whom 10,000 developed nonneuroinvasive WNV disease. The continuing disease burden caused by WNV affirms the need for ongoing surveillance, mosquito control, promotion of personal protection from mosquito bites, and research into additional prevention strategies.

Entities:  

Mesh:

Year:  2010        PMID: 20592686

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  11 in total

1.  Small molecule pan-dengue and West Nile virus NS3 protease inhibitors.

Authors:  Lynne Cregar-Hernandez; Guan-Sheng Jiao; Alan T Johnson; Axel T Lehrer; Teri Ann S Wong; Stephen A Margosiak
Journal:  Antivir Chem Chemother       Date:  2011-05-12

2.  Medical risk factors for severe West Nile Virus disease, United States, 2008-2010.

Authors:  Nicole P Lindsey; J Erin Staples; Jennifer A Lehman; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2012-07       Impact factor: 2.345

3.  West nile virus neuroinvasive disease.

Authors:  Roberta L Debiasi
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

4.  State health department perceived utility of and satisfaction with ArboNET, the U.S. National Arboviral Surveillance System.

Authors:  Nicole P Lindsey; Jennifer A Brown; Lon Kightlinger; Lauren Rosenberg; Marc Fischer
Journal:  Public Health Rep       Date:  2012 Jul-Aug       Impact factor: 2.792

5.  Lack of evidence of increased West Nile virus disease severity in the United States in 2012.

Authors:  Nicole P Lindsey; J Erin Staples; Mark J Delorey; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2013-11-11       Impact factor: 2.345

6.  Initial and long-term costs of patients hospitalized with West Nile virus disease.

Authors:  J Erin Staples; Manjunath B Shankar; James J Sejvar; Martin I Meltzer; Marc Fischer
Journal:  Am J Trop Med Hyg       Date:  2014-02-10       Impact factor: 2.345

7.  The efficacy of inactivated West Nile vaccine (WN-VAX) in mice and monkeys.

Authors:  Yuko Muraki; Takeshi Fujita; Masaaki Matsuura; Isao Fuke; Sadao Manabe; Toyokazu Ishikawa; Yoshinobu Okuno; Kouichi Morita
Journal:  Virol J       Date:  2015-04-09       Impact factor: 4.099

8.  A brief view on molecular diagnosis and surveillance of west nile virus.

Authors:  Pranay Kumar; Shanker K Singh; Yogranjan R Singh; Mayurdhvaj K Jhala
Journal:  Avicenna J Med Biotechnol       Date:  2010-10

9.  Sequence analyses of 2012 West Nile virus isolates from Texas fail to associate viral genetic factors with outbreak magnitude.

Authors:  Nisha K Duggal; Mary D'Anton; Jeannie Xiang; Robyn Seiferth; Joanne Day; Roger Nasci; Aaron C Brault
Journal:  Am J Trop Med Hyg       Date:  2013-07-01       Impact factor: 2.345

10.  West Nile virus and other arboviral diseases--United States, 2012.

Authors: 
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2013-06-28       Impact factor: 17.586

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.